Gofen & Glossberg’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $58M | Buy |
528,104
+2,524
| +0.5% | +$261K | 1.49% | 14 |
|
|
2022
Q3 | $50.9M | Buy |
525,580
+7,825
| +2% | +$834K | 1.44% | 14 |
|
|
2022
Q2 | $56.3M | Buy |
517,755
+5,193
| +1% | +$590K | 1.49% | 13 |
|
|
2022
Q1 | $60.7M | Sell |
512,562
-3,824
| -0.7% | -$474K | 1.38% | 15 |
|
|
2021
Q4 | $72.7M | Sell |
516,386
-2,020
| -0.4% | -$259K | 1.57% | 13 |
|
|
2021
Q3 | $61.2M | Sell |
518,406
-1,483
| -0.3% | -$182K | 1.44% | 15 |
|
|
2021
Q2 | $60.3M | Buy |
519,889
+10,156
| +2% | +$1.18M | 1.43% | 16 |
|
|
2021
Q1 | $61.1M | Buy |
509,733
+1,224
| +0.2% | +$145K | 1.57% | 13 |
|
|
2020
Q4 | $55.7M | Sell |
508,509
-1,795
| -0.4% | -$195K | 1.53% | 15 |
|
|
2020
Q3 | $55.5M | Sell |
510,304
-3,921
| -0.8% | -$398K | 1.71% | 12 |
|
|
2020
Q2 | $47M | Sell |
514,225
-3,797
| -0.7% | -$343K | 1.58% | 13 |
|
|
2020
Q1 | $40.9M | Buy |
518,022
+13,836
| +3% | +$1.15M | 1.6% | 13 |
|
|
2019
Q4 | $43.8M | Buy |
504,186
+8,944
| +2% | +$749K | 1.39% | 17 |
|
|
2019
Q3 | $41.4M | Sell |
495,242
-3,513
| -0.7% | -$298K | 1.4% | 16 |
|
|
2019
Q2 | $41.9M | Buy |
498,755
+4,236
| +0.9% | +$333K | 1.44% | 16 |
|
|
2019
Q1 | $39.5M | Buy |
494,519
+9,461
| +2% | +$704K | 1.4% | 18 |
|
|
2018
Q4 | $35.1M | Buy |
485,058
+6,949
| +1% | +$488K | 1.39% | 18 |
|
|
2018
Q3 | $35.1M | Buy |
478,109
+14,325
| +3% | +$941K | 1.2% | 20 |
|
|
2018
Q2 | $28.3M | Sell |
463,784
-122
| -0% | -$7.4K | 1.05% | 27 |
|
|
2018
Q1 | $27.8M | Buy |
463,906
+231
| +0% | +$13.9K | 1.04% | 24 |
|
|
2017
Q4 | $26.5M | Sell |
463,675
-6,202
| -1% | -$344K | 0.95% | 28 |
|
|
2017
Q3 | $25.1M | Sell |
469,877
-5,022
| -1% | -$252K | 0.93% | 28 |
|
|
2017
Q2 | $23.1M | Buy |
474,899
+787
| +0.2% | +$35.6K | 0.88% | 31 |
|
|
2017
Q1 | $21.1M | Buy |
474,112
+12,130
| +3% | +$524K | 0.83% | 33 |
|
|
2016
Q4 | $17.7M | Buy |
461,982
+3,716
| +0.8% | +$147K | 0.72% | 40 |
|
|
2016
Q3 | $19.4M | Buy |
458,266
+772
| +0.2% | +$33.1K | 0.8% | 36 |
|
|
2016
Q2 | $18M | Buy |
457,494
+11,584
| +3% | +$461K | 0.75% | 39 |
|
|
2016
Q1 | $18.7M | Buy |
445,910
+15,279
| +4% | +$605K | 0.79% | 36 |
|
|
2015
Q4 | $19.3M | Sell |
430,631
-7,904
| -2% | -$349K | 0.84% | 32 |
|
|
2015
Q3 | $17.6M | Buy |
438,535
+1,443
| +0.3% | +$68K | 0.8% | 35 |
|
|
2015
Q2 | $21.5M | Buy |
437,092
+938
| +0.2% | +$45K | 0.91% | 30 |
|
|
2015
Q1 | $20.2M | Buy |
436,154
+2,417
| +0.6% | +$111K | 0.87% | 32 |
|
|
2014
Q4 | $19.5M | Buy |
433,737
+9,417
| +2% | +$410K | 0.84% | 34 |
|
|
2014
Q3 | $17.6M | Buy |
424,320
+74,571
| +21% | +$3.15M | 0.78% | 41 |
|
|
2014
Q2 | $14.3M | Buy |
349,749
+39,552
| +13% | +$1.55M | 0.63% | 47 |
|
|
2014
Q1 | $12.3M | Buy |
310,197
+30,381
| +11% | +$1.17M | 0.58% | 55 |
|
|
2013
Q4 | $10.7M | Buy |
279,816
+1,256
| +0.5% | +$46.3K | 0.5% | 60 |
|
|
2013
Q3 | $9.24M | Sell |
278,560
-4,288
| -2% | -$150K | 0.48% | 62 |
|
|
2013
Q2 | $9.87M | Buy |
+282,848
| New | +$10.4M | 0.53% | 61 |
|
Other funds holding ABT
AWA
Gofen & Glossberg's ABT Position: Q4 2022 in Review
Gofen & Glossberg increased its Abbott (ABT) stake by 0.48% in Q4 2022, buying an estimated $261K and bringing the position to 528,104 shares worth $58M. The position accounts for 1.49% of the portfolio, ranked #14.
Gofen & Glossberg first reported a position in ABT in Q2 2013 and has held it in 39 quarters since. The position peaked at $72.7M in Q4 2021. 2,765 funds tracked by Wall St. Rank hold ABT as of Q4 2022.
- Gofen & Glossberg held 528,104 shares of Abbott worth $58M as of Q4 2022.
- Gofen & Glossberg bought 2,524 Abbott shares in Q4 2022, an estimated $261K.
- Abbott made up 1.49% of Gofen & Glossberg's portfolio in Q4 2022, its #14 holding.
- Gofen & Glossberg first reported a position in Abbott in Q2 2013 and has held it in 39 quarters since.
- Gofen & Glossberg's Abbott position peaked at $72.7M in Q4 2021.
- 2,765 funds tracked by Wall St. Rank held Abbott as of Q4 2022.
Based on Gofen & Glossberg's 13F filing for Q4 2022, filed 13 Jan 2023.